suPAR assay in clinical routine: evaluation one year after introduction in high automation core lab of the A. Gemelli hospital An article indicating how suPAR was implemented in the A. Gemelli Hospital (Rome, Italy), beyond [...]
ViroGates announces the publication of a new study that shows suPAR causes cardiovascular disease The Journal of Clinical Investigation states: “Using clinical, genetic and experimental data, a collaborative study between researchers from USA, Sweden and [...]
NEW STUDY Soluble urokinase plasminogen activator receptor and survival in elective cardiac surgery Results Besides long-term mortality, the biomarker score had an excellent performance in predicting one-year mortality and hospitalization due to heart failure. [...]
NEW STUDY Association between variables measured in the ambulance and in-hospital mortality among adult patients with and without infection: a prospective cohort study Conclusions: suPAR ≥ 8.0 ng/mL was associated with mortality in patients [...]
NEW STUDY Self‑rated health and chronic infammation are related and independently associated with hospitalization and long‑term mortality in the general population Results Relationship between SRH and suPAR levels. The participants had a median suPAR [...]
NEW STUDY Soluble Urokinase Plasminogen Activator Receptor Levels and Outcomes in Patients with Heart Failure Conclusion suPAR levels are higher in HF compared to non-HF, are strongly predictive of outcomes, and combined with BNP, [...]
STUDY Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis People with kidney disease are disproportionately affected by atherosclerosis for unclear reasons. Soluble urokinase plasminogen activator receptor (suPAR) is an immune-derived [...]
NEW STUDY Soluble urokinase-type plasminogen activator receptor improves early risk stratification in cardiogenic shock Conclusion SuPAR associates with mortality and improves risk stratification independently of other previously known risk factors in CS patients. Aims Soluble [...]
48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.
New Webinar
